In contrast to clathrin-mediated endocytosis (CME) which is well characterized and understood, little is known about the regulation and machinery underlying clathrin-independent endocytosis (CIE). There is also a wide variation in the requirements each individual CIE cargo has for its internalization. Recent studies have shown that CIE is affected by glycosylation and glycan interactions. We briefly review these studies and explore how these studies mesh with one another. We then discuss what this sensitivity to glycan interactions could indicate for the regulation of CIE. We address the spectrum of responses CIE has been shown to have with respect to changes in glycan interactions and attempt to reconcile disparate observations onto a shared conceptual landscape. We focus on the mechanisms by which cells can alter the glycan interactions at the plasma membrane and propose that glycosylation and glycan interactions could provide cells with a tool box with which cells can manipulate CIE. Altered glycosylation is often associated with a number of diseases and we discuss how under different disease settings, glycosylation-based modulation of CIE could play a role in disease progression.
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| INTRODUCTION
Endocytosis is known to play essential roles in numerous cell functions. 1 The best characterized form of endocytosis is clathrinmediated endocytosis (CME), which has well-defined machinery, 2 a visible coat protein (ie, clathrin) and shared cytoplasmic sorting motifs with which cargo can bind specifically to adaptor proteins and clathrin.
In contrast, there is little known about the machinery underlying clathrin-independent endocytosis (CIE) and efforts to identify and characterize the common shared cellular machinery involved in CIE's regulation have not been fruitful. 3 There is no apparent cytoplasmic coat protein in CIE analogous to clathrin in CME. The field has also been distracted by the heterogeneity of CIE observed in different cells types. 4, 5 Recent studies have suggested that glycosylation and extracellular galectins can play a role in mediating CIE. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Our group has also recently published a study showing that two of the CIE cargo proteins we follow are differentially sensitive to changes in glycosylation and the presence and interactions with galectins, raising the possibility that glycosylation and galectins could modulate cargo entry by CIE. 15 These findings suggest that galectins could serve as extracellular machinery facilitating or inhibiting cargo entry from the extracellular/-lumenal side of the membrane (Figure 1) .
One of the factors that has made finding shared machinery so challenging is that CIE is a bulk pathway and as such is responsible for the internalization of a diverse and varied assortment of proteins. 3, 12, 16 Unlike CME, where each cargo protein has cytoplasmic sorting motifs, CIE is responsible for internalizing proteins, from transmembrane proteins like the major histocompatibility complex (MHC)
class I to GPI-anchored proteins like CD59, which do not have a cytoplasmic domain let alone a sorting sequence.
The extent of the diversity of CIE cargo is illustrated by the numerous pathways of CIE that have been described. These pathways can be constitutive or ligand stimulated, dynamin-dependent or dynamin-independent, associated with arf6 or independent. Fast endophilin-mediate endocytosis (FEME) (17) and ultrafast endocytosis 17 are examples of ligand stimulated CIE that are characteristically very rapid and require endophilin, dynamin, actin and synaptojanin.
The FEME pathway is responsible for the uptake of cargo like the epidermal growth factor receptor (at high concentrations), interleukin 2 and a number of other G-Protein-coupled receptors. 17, 18 Constitutive processes like the clathrin-independent carrier GPI-enriched compartment (CLIC/GEEC) are responsible for the uptake of cargo-like CD44 have been shown to be dependent on GRAF1, cdc42, Arf1 and actin polymerization but are independent of dynamin. 19 Cargo-like MHC class I and CD59 are also endocytosed constitutively in association with Arf6 and independent of dynamin. 20, 21 More comprehensive overviews of the various types of CIE can be found in these reviews. [1] [2] [3] [4] [5] 16 While each of these pathways has a number of unique components, they also share a few common requirements such as a need for cholesterol, lipid rafts and in many cases actin polymerization.
Another potential shared feature of all these different CIE cargo proteins is glycosylation. Almost every single protein at the cell surface is glycosylated. Recent studies from our group as well as others have highlighted how glycosylation can play important roles in CIE.
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| GLYCOSYLATION OF PLASMA MEMBRANE PROTEINS (CARGO) AND INTERACTIONS WITH CELLULAR LECTINS
Glycosylation is an important posttranslational modification. It has long been known that altered glycosylation is a hallmark of cancer. [22] [23] [24] This fact has been leveraged in the development of cancer biomarker like CA19-9 which is a carbohydrate antigen that is used as a diagnostic marker for pancreatic and gastrointestinal cancer. 25, 26 While these changes were initially viewed as passive by prod- Unlike the biosynthetic processes of most complex macromolecules in cells like DNA, RNA and proteins, glycosylation is a complex, posttranslation modification that is nontemplate driven. [32] [33] [34] [35] [36] [37] [38] As a result, the patterns of glycans produced on surface proteins are heterogeneous and can shift based on changes in the availability of enzymes or their sugar substrates in the ER and Golgi. Glycans can be detected by a variety of lectins that bind to specific glycan linkages. For example, concanavalin A binds to high mannose structures and Ricinus communis Agglutinin binds to β-galactoside. 39, 40 The degree or extent of glycosylation on an individual protein (ie, the number of glycans a protein displays) is also genetically encoded by the number of NXT/S motifs a protein has in its sequence. 8, 41 A more comprehensive overview of glycosylation can be found in these reviews. 28, 33, 35, 37, 38, 42 Galectins are a family of β-galactoside-binding lectins. 43 They are synthesized in the cytoplasm where they are known to play a number of intracellular roles. 44 In addition, a proportion of these lectins are secreted by the cell by nonclassical secretion. 45 Once outside the cell, galectins can bind to β-galactoside structures on cellular surfaces and mediate functional effects. 7,9,43,45-48 The galectins are the predominant class of mammalian cellular lectins that have been shown to influence CIE. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] There are three main classes of galectins:
Differences in mechanistic understanding of CIE and CME. CME has a well characterized mechanism with numerous components and their roles identified. AP2 subunits bind to motifs on CME cargo, they recruit clathrin which then helps to form a well-defined coat on the endosomes, dynamin then helps mediate scission of these endosomes. In contrast, there is little known about the machinery that drives CIE. Galectins and glycan interactions could serve as an extracellular coat and play a role in mediating CIE from the lumenal side of these endosomes 12 In their study, they show that galectin 3 can be observed in endocytic pits by electron microscopy, that addition of exogenous galectin 3 can stimulate the internalization of CD44 and further that these galectins can drive membrane bending in giant unilamellar vesicles. Their results suggest that the initial membrane curvature in CLIC/GEECs can depend on a mechanism termed the "GL-Lect"
hypothesis wherein extracellular clustering of cargo proteins mediated by galectin 3 or shiga and cholera toxins in conjunction with glycolipids drives the initial bending of the membrane. 6, 7 Work from the Nabi and Dennis labs focused on the CME of various receptors, but coincidentally suggested a role for galectin-glycan interactions in CIE as well. They altered glycosyltransferase expression levels to induce changes in glycan patterns. These altered glycan patterns increased galectin glycan interactions and resulted in a large network of interactions termed the galectin lattice that sequesters cargolike tumor growth factor β receptor and epidermal growth factor receptor (which internalizes by CIE at high concentrations 49, 50 ) at the cell surface thus inhibiting their internalization. 10, 11 This inhibitory role of the galectin lattice on EGFR CIE was then directly characterized by the Yarema lab. 1,3,4-O-Bu 3 ManNAc (a sugar analog that increases the flux through the sialic acid biosynthetic pathway) was used as a means of increasing cell surface sialylation. Increased sialylation masked the epitopes for galectin binding and led to a disruption in the galectin lattice. This disruption of the galectin lattice stimulated CIE specifically. 13, 14 The juxtaposition of these two contrasting modes of activity has made interpreting the role of galectins and glycosylation challenging.
Our recent study proposes a conceptual landscape that we believe can help reconcile these two contrasting views on the role of glycosylation in CIE. 15 While it has been hinted at in previous studies that the two modes of action (stimulatory vs inhibitory) could be the two ends of a spectrum, 12, 47 our study provides an in depth look at how proteins can transition between these two modes of action ( Figure 2 ). We demonstrate that as the level of glycan interactions increases (from left to right in Figure 2 ), the internalization of CD59 is initially stimulated due to enhanced endocytic pit entry and as the level of glycan interactions continues to increase it then transitions into the cell sequestration mode of action and its internalization is inhibited. The Johannes lab also noticed this type of behavior for CD44, where if all glycan interaction were disrupted and then exogenous galectin 3 was reintroduced, initially there was a stimulation in CIE but at higher concentrations of exogenous galectin 3, they noticed a suppression in CIE. 12 Our study also highlighted that within the same cell line distinct cargo could start at different positions on the spectrum. In untreated Hela cells while CD59 started on the inhibitory side of the spectrum MHC class I was on the stimulatory side of the spectrum. Thus, increasing glycan interactions in these cells led to an increase in internalization of MHC class I and a decrease in internalization of CD59. 15 This observation could also involve aspects of the GL-Lect hypothesis 6,7 because an important difference between MHC class I and CD59 is that one is an integral membrane protein and the other is a GPI-anchored protein and as such they occupy distinct positions in the membrane bending mechanism presented in that model. This intrinsic difference in these two cargos could account for the differences in sensitivity to changes in glycan interactions and the distinct response landscapes they are observed to have. 
| THE POSSIBLE SCOPE OF CIE REGULATION VIA GLYCAN INTERACTIONS
Glycosylation has an underappreciated ability to code information.
N-linked glycosylation alone has a large amount of structural and pattern flexibility based on the nontemplate driven nature of its synthesis. As a result, the glycan patterns a cell produces can be shifted based on genetic changes (expression of glycosyltransferases, sugar transporters, etc.) 32 and substrate availability (changes in nutrient availability). [13] [14] [15] This allows glycan patterns to represent an integration of genetic and environmental information ( Figure 2 ). In addition, the extent of glycosylation of individual proteins is subject to the number of available glycosylation sites on the protein and transit time through the ER and Golgi. As a result, different protein can also have subtly different information coded onto them based both on factors that are intrinsic to the proteins as well as extrinsic.
In addition to this, a cell can also control the degree to which these changes in glycosylation are transduced into functional effects by modulating the other side of the glycan interaction (ie, the secreted galectins). The amount of galectin available to interact with glycans can be controlled by altering their expression level, secretion or which type of galectin is predominantly expressed.
This could provide the cell a unique tool box with which it could regulate CIE. While CIE is primarily thought of as a bulk pathway it is essential in numerous cellular functions such as plasma membrane turnover, recycling and repair, cell spreading, cell migration cell polarization and modulation of intercellular signaling. For instance, galectin 3 serum levels are often observed to be elevated in cancer, [56] [57] [58] [59] this could be a way in which a tumor alters or regulates CIE (among other things) at potential secondary sites for metastasis.
Elevated serum galectin 3 levels are also associated with almost all types of cardiovascular disease and are generally a prognostic marker for poorer outcomes. [60] [61] [62] High levels of circulating galectin 3 were found to be associated with depression in patients with type 1 diabetes. 63 Elevated serum levels of galectin 3 are also found to precede chronic kidney disease 64 and are known to be associated with schizophrenia. 65 Aside from its dysregulation in these disease contexts, galectin 3 also plays important roles in proper bone cell differentiation and bone remodeling, 66 as well as in driving oligodendrocyte differentiation. 67 In all these various biological situations the correct balance of galectin 3 is important and shifting that balance has profound effects. Galectin-3-mediated modulation of CIE could potentially be a factor of the molecular mechanism underlying the effect of altered galectin 3 levels in these various contexts. The key role galectin 3 plays in the modulation of CIE also highlights the importance of a better understanding of the regulation of galectin synthesis, stability and how these proteins are secreted.
| CONCLUSION
Galectin-glycan interactions organize the cell surface and can either promote or inhibit cargo entry by CIE. These interactions can also promote the formation of invaginations (pits). Our study along with a number of other recent studies suggests that CIE can be regulated by glycan interaction and that this regulation may be cargo protein specific. These galectin-glycan interactions could serve as extracellular machinery facilitating CIE and providing a unifying mode of regulation and control. Glycan interactions are a versatile tool that cells could use to regulate CIE in complex and nuanced ways ranging from the single cell level to large populations, and possibly even communicate some of this information across macroscale distances.
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